Revised: May 2025 PRINCIPAL DISPLAY PANEL - 3 mL Pen Carton NDC 0024-5761-05 Rx only SOLIQUA 100/33 (insulin glargine and lixisenatide) injection For Single Patient Use Only 100 units/mL and 33 mcg/mL With each unit of insulin glargine, the pen also delivers 0.33 mcg of lixisenatide Only for Doses from 15 to 60 Units For subcutaneous injection only Dispense with the medication guide Solution for injection in a SoloStar disposable insulin delivery device Never remove medication using a syringe Do not mix with other insulins Use only if solution is clear and colorless with no particles visible Five 3 mL prefilled pens (15 mL total) Dispense in this sealed carton *Needles not included (see back panel) sanofi Biological Products Related to Soliqua Find detailed information on biosimilars for this medication
Diabetes and lung disease: an underestimated relationship
The possibility of offering new hope to individuals struggling with addiction is what makes this work so meaningful. Original study: DOI 10.1038/s41598-025-17927-w Authors: Fatima Quddos, graduate, Virginia Tech Translational Biology, Medicine, and Health Graduate Program Mary Fowler, research assistant and programs coordinator, Fralin Biomedical Research Institute at VTC Ana Carolina de Lima Bovo, Ph.D., postdoctoral associate, Fralin Biomedical Research Institute at VTC Zacarya Elbash, research assistant, Fralin Biomedical Research Institute at VTC Allison N
Our team recommends it as first-line for anyone with a history of chronic constipation or IBS-C
From there, Kristin encourages a simple approach: Take baby steps
